Healthcare - Biotechnology - NASDAQ - US
$ 0.8284
-18 %
$ 45.7 M
Market Cap
-0.58
P/E
BALANCE SHEET
204 M
ASSETS
146 M
LIABILITIES
58 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Omega Therapeutics, Inc.
| Current Assets | 89.9 M |
| Cash & Short-Term Investments | 73.4 M |
| Receivables | 6.99 M |
| Other Current Assets | 9.47 M |
| Non-Current Assets | 114 M |
| Long-Term Investments | 0 |
| PP&E | 114 M |
| Other Non-Current Assets | 435 K |
| Current Liabilities | 26.8 M |
| Accounts Payable | 1.62 M |
| Short-Term Debt | 26.6 M |
| Other Current Liabilities | -1.41 M |
| Non-Current Liabilities | 120 M |
| Long-Term Debt | 113 M |
| Other Non-Current Liabilities | 6.42 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 68.4 | 70.6 | 186.5 | 23.0 | 2.3 |
| Short Term Investments | 5.0 | 54.1 | 38.8 | 0 | 0 |
| Receivables | 7.0 | 1.8 | 0.5 | 0.2 | 5 K |
| Inventory | 0 | 41.2 | (0.3) | 0 | 0 |
| Other Current Assets | 9.5 | 11.1 | 3.4 | 0.9 | 0.4 |
| Total Current Assets | 89.9 | 124.7 | 229.3 | 24.0 | 2.7 |
| PP&E | 114.0 | 7.9 | 3.6 | 3.5 | 2.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.3 | 0.3 | 0.3 | 0.3 |
| Other Long Term Assets | 0.4 | 13.1 | 0.1 | 0.3 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 204.4 | 146.0 | 233.3 | 28.1 | 6.1 |
| LIABILITIES | |||||
| Accounts Payable | 1.6 | 3.1 | 2.1 | 1.1 | 0.9 |
| Short Term Debt | 26.6 | 6.4 | 0 | 3.0 | 0 |
| Other Current Liabilities | (1.4) | 12.5 | 9.9 | 3.6 | 1.3 |
| Total Current Liabilities | 26.8 | 22.0 | 12.0 | 7.7 | 2.2 |
| Long Term Debt | 113.1 | 17.7 | 19.9 | 8.7 | 11.9 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 6.4 | 0.3 | 0.9 | 76.3 | 27.9 |
| Total Liabilities | 146.3 | 40.0 | 32.7 | 92.7 | 42.0 |
| EQUITY | |||||
| Common Stock | 55 K | 48 K | 48 K | 5 K | 5 K |
| Retained Earnings | (334.6) | (237.2) | (134.5) | (66.2) | (36.8) |
| Other Accumulative Comprehensive Income/Loss | 14 K | (0.5) | 62 K | (75.2) | (26.7) |
| Total Equity | 58.0 | 106.0 | 200.6 | (64.6) | (35.9) |
| Total Liabilities and Equity | 204.4 | 146.0 | 233.3 | 28.1 | 6.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 54.0 | 47.9 | 47.8 | 47.8 | 47.8 |